Patient selection may affect gene therapy success. Dominant negative effects observed for ornithine transcarbamylase in mouse and human hepatocytes.

We have achieved significant improvement of ornithine transcarbamylase deficiency (OTCD) in a mouse model through adenoviral-mediated gene transfer of the human ornithine transcarbamylase cDNA. Substantial reduction in orotic aciduria was observed within 24 h of treatment. Metabolic correction was l...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Invest
Autors principals:	Morsy, M A, Zhao, J Z, Ngo, T T, Warman, A W, O'Brien, W E, Graham, F L, Caskey, C T
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Clinical Investigation 1996
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC507121/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8609240/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI118482
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!